Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030305 (
pancreatitis
)
16,014
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objective:
Defective mucus production in the pancreas may be an important factor in the initiation and progression of chronic pancreatitis (CP), therefore we aimed to (i) investigate the qualitative and quantitative changes of mucus both in human CP and in an experimental
pancreatitis
model and (ii) to correlate the mucus phenotype with epithelial ion transport function.
Design:
Utilizing human tissue samples and a murine model of cerulein induced CP we measured pancreatic ductal mucus content by morphometric analysis and the relative expression of different mucins in health and disease. Pancreatic fluid secretion in CP model was measured
in vivo
by magnetic resonance cholangiopancreatography (MRCP) and
in vitro
on cultured pancreatic ducts. Time-changes of ductal secretory function were correlated to those of the mucin production.
Results:
We demonstrate increased mucus content in the small pancreatic ducts in CP. Secretory mucins
MUC6
and
MUC5B
were upregulated in human,
Muc6
in mouse CP.
In vivo
and
in vitro
fluid secretion was decreased in cerulein-induced CP. Analysis of time-course changes showed that impaired ductal ion transport is paralleled by increased
Muc6
expression.
Conclusion:
Mucus accumulation in the small ducts is a combined effect of mucus hypersecretion and epithelial fluid secretion defect, which may lead to ductal obstruction. These results suggest that imbalance of mucus homeostasis may have an important role in the early-phase development of CP, which may have novel diagnostic and therapeutic implications.
...
PMID:Ductal Mucus Obstruction and Reduced Fluid Secretion Are Early Defects in Chronic Pancreatitis. 2989 15